- Sunitib in adjuvant treatment for renal cell carcinoma2017 | Publication without faculty affiliation
- Adjuvantní terapie melanomu v přehledu2021 | First Faculty of Medicine
- Capecitabin e and oxaliplatin (XELOX) in adjuvant therapy of colorectal cancer. Results of the NO16968 (XELOXA) trial2010 | First Faculty of Medicine
- Breast cancer - adjuvant therapy in 2000Publication without faculty affiliation
- The role of light, lasers and immunomodulators as primary or adjuvant treatment of non-melanomcytic neoplasia2009 | First Faculty of Medicine
- Adjuvant chemotherapy in hormonal-dependent breast cancer patients - options in using of multigene assays2019 | First Faculty of Medicine
- Osteosarcoma of the urinary bladder in a patient with prolonged adjuvant therapy, primarily prostate cancer2011 | Faculty of Medicine in Hradec Králové
- Natural compounds and structured biological systems in prevention and adjuvant therapy of infectious diseases of pigs +12007 | Publication without faculty affiliation
- Osteosarcoma of the urinary bladder in a patient after prolonged adjuvant therapy for primary urothelial bladder carcinoma2015 | Faculty of Medicine in Hradec Králové
- Generalizovaný maligní melanom léčený kombinací BRAF a MEK inhibitorů ve 3. linii terapie2023 | First Faculty of Medicine
- Low dose morphine adjuvant therapy for enhanced efficacy of antipsychotic drug action: potential involvement of endogenous morphine in the pathophysiology of schizophrenia2012 | First Faculty of Medicine
- Adjuvant therapy for melanoma in real world2023 | Faculty of Medicine in Hradec Králové
- Genomic tests as predictors of breast cancer patients' prognosis2016 | First Faculty of Medicine
- A case study of a patient with advanced, KRAS wild-type colorectal carcinoma, treated with cetuximab2013 | Second Faculty of Medicine
- Renální karcinom2017 | First Faculty of Medicine
- Adjuvant therapy of malignant melanoma: general and practical experience2021 | Faculty of Medicine in Hradec Králové
- Cílená léčba inhibitory CDK4/6 v kombinaci s hormonální terapií v první linii léčby metastatického karcinomu prsu u pacientky s generalizací do skeletu sedm let od ukončení adjuvantní terapie2022 | First Faculty of Medicine
- Spectrum of patients with refractory epilepsy: Local analysis of clinical evaluation of SKATE in the Czech Republic2005 | First Faculty of Medicine, Second Faculty of Medicine
- Neúčinnost cyklosporinu jako adjuvantní terapie ke kortikoidům při léčbě pemfigu. Překlad (Ioannides, D. - Chrysomallis, F. - Bystrin, J. C. : Ineffectiveness of Cyclosporine as an Adjuvant to Corticostereoids in the Treatment of Pemphigus)2001 | Publication without faculty affiliation
- Personalization of neo/adjuvant treatment of HER2-positive breast cancer is the key to achieve the best results2022 | First Faculty of Medicine
- Retrospective analysis of locally advanced rectal carcinoma treatment at the institute of radiation oncology in the last six years2006 | First Faculty of Medicine
- Early detection of biochemical recurrence after radical prostatectomy and its meaning for adjuvant treatment.2007 | Second Faculty of Medicine
- CHAPTER 10: The Role of Melatonin in Etiopathogenesis and Therapy of Autism Spectrum Disorders2010 | First Faculty of Medicine
- Přínos tyrosinkinázových inhibitorů EGFR v adjuvantní léčbě karcinomů plic2023 | Faculty of Medicine in Pilsen
- Přínos tyrosinkinázových inhibitorů EGFR v adjuvantní léčbě karcinomu plic2023 | Faculty of Medicine in Pilsen
- Report of University Hospital Hradec Králové to the clinical trial protocol No: CRAD00IN2301Publication without faculty affiliation
- Rituximab in the Treatment of Pemphigus Vulgaris - Case Report2020 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CRAD001N2301Publication without faculty affiliation
- Immunotherapy in the treatment of urological cancers2016 | First Faculty of Medicine